Current alignment between the practice patterns of gastrointestinal (GI) cancer clinical investigators (CI) and general medical oncologists (MO) in the treatment of metastatic GI cancers

被引：0
|
作者：
Miller, Kirsten [1 ]
Ziel, Kathryn [1 ]
Kelly, Gloria [1 ]
Paley, Douglas [1 ]
Moss, Jonathan [1 ]
Love, Neil [1 ]
机构：
[1] Res Practice, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18193
引用
收藏
页数：5
相关论文
共 4 条
  • [1] Current alignment between the practice patterns of gastrointestinal (GI) cancer clinical investigators (CI) and general medical oncologists (MO) in the treatment of metastatic GI cancers.
    Love, Neil
    Kelly, Gloria
    Miller, Kirsten
    Paley, Douglas
    Moss, Jonathan
    Ziel, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Female representation in clinical trials leading to FDA cancer drug approvals for gastrointestinal (GI) cancers between 2008 to 2018
    Mendis, Shehara Ramyalini
    Anand, Seerat
    Dasari, Arvind
    Unger, Joseph M.
    Gothwal, Anirudh
    Ellis, Lee M.
    Varadhachary, Gauri Rajani
    Kopetz, Scott
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Loree, Jonathan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] Changes in Functional Assessment of Cancer Therapy: General (FACT-G) to predict treatment response and survival outcomes in patients with metastatic gastrointestinal (GI) cancer.
    Jarnagin, Joy X.
    Saraf, Anurag
    Chi, Gary
    Baiev, Islam
    Mojtahed, Amirkasra
    Allen, Jill N.
    Ryan, David P.
    Clark, Jeffrey William
    Blaszkowsky, Lawrence Scott
    Giantonio, Bruce J.
    Weekes, Colin D.
    Klempner, Samuel J.
    Franses, Joseph Wang
    Roeland, Eric
    Goyal, Lipika
    Horick, Nora K.
    Corcoran, Ryan Bruce
    Parikh, Aparna Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Self-stated and actual practice patterns of general medical oncologists (MO) regarding the use of predictive biomarkers to guide treatment for patients (pts) with chronic lymphocytic leukemia (CLL).
    Escalon, Maricer P.
    Wierda, William G.
    LaCasce, Ann S.
    Jevremovic, Dragan
    Harwin, William N.
    Kelly, Gloria
    Miller, Kirsten
    Paley, Douglas
    Nelson, Joe
    Ziel, Kathryn
    Love, Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
1